Trade MEDS stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
DataMeds AI, Inc. (MEDS) is trading at US$3.76, down 18.97% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$4.19M. Over the past 52 weeks, MEDS has traded between US$0.82 and US$73.00. On Syfe you can trade MEDS with $0 commission and add it to your watchlist.
| Previous close | US$4.64 |
|---|---|
| Market cap | US$4.19M |
| 52-week range | US$0.82 – US$73.00 |
| Volume | 15.39M |
| Exchange | US |
Add to Watchlist
Set Price Alert
DataMeds AI, Inc.
DataMeds AI, Inc. operates as a holding company centered around pharmaceuticals and healthcare services. Its business portfolio consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. The company was founded by Ajjarapu Surendra on September 6, 2022 and is headquartered in Tampa, FL.
Year: 2025
DataMeds AI, Inc. (MEDS) stock is trading at US$3.76, -18.97% from the previous close of US$4.64.
The market cap for DataMeds AI, Inc. (MEDS) stock is approximately US$4.19M.
The 52-week high for DataMeds AI, Inc. (MEDS) stock is US$73.00.
The 52-week low for DataMeds AI, Inc. (MEDS) stock is US$0.82.
DataMeds AI, Inc. (MEDS) does not currently pay a dividend.
Stay on top of MEDS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
